Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.64 |
| ▸ | CTSB | P07858 | 2/20 | 0.64 |
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.54 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.54 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.52 |
| ▸ | CXCL8 | P10145 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437939 | 0.96 | CAPN1 (0.60) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL29437937 | 0.96 | CAPN1 (0.63) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL30477480 | 0.94 | CAPN1 (0.65) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL29437935 | 0.94 | DPP3 (0.58) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL29437938 | 0.90 | CAPN1 (0.61) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL29555002 | 0.88 | CAPN1 (0.54) | CAPN1CTSBDPP3CXCR4 | |
| SCHEMBL29416081 | 0.86 | DPP3 (0.58) | CAPN1CTSBDPP3CXCR4KISS1R | |
| SCHEMBL30442994 | 0.86 | DPP3 (0.56) | CAPN1CTSBDPP3CXCR4NTSR2 | |
| SCHEMBL29713766 | 0.85 | DPP3 (0.63) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL29575470 | 0.84 | DPP3 (0.61) | CAPN1CTSBDPP3NTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023013755-A1 | CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2023-02-09 | — | — | WO | disclosed |